Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20064211HPVENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TVIS20064150HPVENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TVIS44027967HTLV-1ENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TVIS44049811HTLV-1ENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TVIS44035846HTLV-1ENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TCGA Plot Options
Drug Information
GeneHTR2C
DrugBank IDDB06594
Drug NameAgomelatine
Target IDBE0000533
UniProt IDP28335
Regulation Typeantagonist
PubMed IDs15289999
CitationsMillan MJ, Brocco M, Gobert A, Dekeyne A: Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology (Berl). 2005 Feb;177(4):448-58. Epub 2004 Jul 31.
GroupsApproved; Investigational
Direct ClassificationN-acetyl-2-arylethylamines
SMILESCOC1=CC2=C(CCNC(C)=O)C=CC=C2C=C1
Pathways
PharmGKBPA165958363
ChEMBLCHEMBL10878